Subscribe to RSS - ResMed

ResMed

OSA affects more Europeans than previously thought, ResMed says

 - 
09/19/2018

PARIS – Approximately 175 million Europeans have obstructive sleep apnea, including 90 million with moderate to severe OSA, according to an abstract presented by ResMed at the European Respiratory Society’s annual ERS Congress.

F&P responds to ResMed

 - 
09/13/2018

IRVINE, Calif. – Fisher & Paykel Healthcare has filed a complaint with the U.S. International Trade Commission seeking an exclusion order to prevent the import and sale of ResMed’s AirFit P10 range of nasal pillows masks in the United States.

Growth in the sleep market continues

 - 
09/12/2018

BOSTON – Sleep center patient volume grew 7% in the last 12 months and is expected to grow 9% in the next 12 months, according to the results of a new survey conducted by Needham & Co.

In brief: Group wants liquid oxygen out, ASAA pushes for progress in sleep apnea treatment

 - 
09/07/2018

WASHINGTON – A coalition of 20 patient and physician groups is asking CMS to remove liquid oxygen from its competitive bidding program.

ResMed renews patent battle with F&P

 - 
09/04/2018

SAN DIEGO – ResMed has filed a new petition with the U.S. International Trade Commission to stop the alleged infringement of its patented technology by New Zealand-based Fisher & Paykel Healthcare. ResMed seeks an order banning the importation and sale in the U.S.

Short takes: MK Battery, ResMed, Invacare

 - 
08/30/2018

In conjunction with NRRTS, MK Battery has received approval for a 0.1 CEU course titled “Battery Technologies.” The one-hour course provides in-depth instruction on the proper selection, installation, care and maintenance of batteries used in power mobili

ResMed readies to scale POC business

 - 
08/03/2018

SAN DIEGO – ResMed plans to take a “partnership” approach with HME providers when it more widely launches its portable oxygen concentrator in fiscal year 2019, CEO Mick Farrell said during a conference call last week to discuss the company’s most recent financial results.

ResMed closes year strong, says CEO

 - 
08/03/2018

SAN DIEGO – ResMed has reported revenues of $623.6 million for the fourth quarter of fiscal year 2018, a 12% increase compared to the same period of 2017.

Efficiency at heart of connected care

 - 
07/30/2018

Keeping a tight lid on expenses is paramount for HME providers to keep their finances healthy, and technology can serve as an effective tool for reaching that goal, technology specialists say.

In brief: Upstate HomeCare leverages HealthSqyre for growth, ResMed joins forces with Verily

 - 
07/13/2018

CLINTON, N.Y. – Upstate HomeCare has announced a strategic partnership with HealthSqyre, a Denver-based online CPAP marketplace.

Pages